Product Specifications
| Catalog Number | BIC-4437E |
|---|---|
| Target | Fibroblast growth factor 4 |
| Target Symbol | FGF4 |
| Species | Human |
| Expression System | CHO |
| Expression Region | Ala31-Leu206 |
| Molecular Weight | 19.3 kDa |
| Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining) |
| Endotoxin | ≤10 EU/mg by the LAL method |
| Formulation | Lyophilized |
| Buffer | PBS,5% mannitol and 0.01% Tween 80, pH7.4 |
| Reconstitution | It is recommended to redissolve in sterile deionized water. |
| Storage & Stability | 36 months at -20°C to -80°C in lyophilized state6 months at -20°C to -80°C under sterile conditions after reconstitution7-10 days at 2°C to 8°C under sterile conditions after reconstitutionUse a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | The product is shipped with blue ice |
| Lead Time | Products are in stock,but custom products may require further consultation |
| Accession | P08620 |
| Alternative Names | Fibroblast growth factor 4; FGF-4; Heparin secretory-transforming protein 1; HST; HST-1; HSTF-1; Heparin-binding growth factor 4; HBGF-4; Transforming protein KS3; FGF4; HST; HSTF1; KS3 |
Bioactivity
Measured in a cell proliferation assay using NIH3T3 mouse embryonic fibroblast cells. The ED50 for this effect is 0.25-1 ng/mL
Quality Data
Recombinant Human FGF4 (Cat. No. BIC-4437E) SDS-PAGE under reducing (R) & Non-reducing conditions.
